These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10751080)

  • 1. DOTS in Haiti.
    Ollé-Goig JE
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
    Grosset PJ
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):549-50. PubMed ID: 10423215
    [No Abstract]   [Full Text] [Related]  

  • 3. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multidrug-resistant tuberculosis. Remarks and reflections on a controversial subject of current utmost importance].
    Ausina V
    Med Clin (Barc); 1996 Jan; 106(1):15-8. PubMed ID: 8750536
    [No Abstract]   [Full Text] [Related]  

  • 6. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic mass caused by Mycobacterium tuberculosis with reduced drug sensitivity.
    Small G; Wilks D
    J Infect; 2001 Apr; 42(3):201-2. PubMed ID: 11545552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World tuberculosis control: how far have we to go?
    Enarson DA
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug resistant tuberculosis in north London.
    Commun Dis Rep CDR Wkly; 2000 Aug; 10(32):285, 288. PubMed ID: 10958060
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberculosis in the 21st centruy].
    Casal M
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):207-8. PubMed ID: 10974762
    [No Abstract]   [Full Text] [Related]  

  • 12. Terizidone.
    Vora A
    J Assoc Physicians India; 2010 Apr; 58():267-8. PubMed ID: 21046890
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multidrug-resistant tuberculosis].
    Mori T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371
    [No Abstract]   [Full Text] [Related]  

  • 14. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of multidrug resistance on global tuberculosis control.
    Cox H; Hargreaves S; Ismailov G
    Lancet; 2003 Nov; 362(9398):1858-9. PubMed ID: 14654338
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
    Hillemann D; Kubica T; Agzamova R; Venera B; Rüsch-Gerdes S; Niemann S
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.